From opportunity to plan
We assess the product, target market, regulatory route, commercial model and potential partners before resources are committed.
Practical market entry
Our work can connect regulatory readiness with distribution, coding, reimbursement and launch considerations.
Access readiness before launch
We help companies consider the pricing pathway, coding and coverage readiness, relevant procurement or tender routes, distributor and import structure, and launch sequencing early in the UAE plan.
Related insight: Abu Dhabi life sciences
Explore what Abu Dhabi’s AI drug-discovery, genomic-data and advanced-therapy initiatives may mean for pharmaceutical and biotechnology companies assessing UAE market entry.
Read ViaFarma’s analysisQuestions from manufacturing and regulatory teams
What should be reviewed before committing to UAE market entry?
Confirm the product classification and applicable registration and import pathway with the relevant authority. For the investment decision, ViaFarma recommends testing target demand, price and coverage assumptions, supply economics and distributor responsibilities before committing to launch volumes or exclusivity.
How we start
Share the product or scope, target authority or market, and desired timing. We will return with an initial assessment and clear next steps.